Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CNS Pharmaceuticals, Inc.CNSP · Entity 8048 | Director | November 17, 2025 | November 20, 2025 |
| Quantum-Si IncQSI · Entity 6440 | Chief Financial Officer | September 21, 2026 | September 23, 2026 |
| STAR EQUITY HOLDINGS, INC.DRAD · Entity 76212 | Chief Financial Officer | February 28, 2018 | March 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CNS Pharmaceuticals, Inc.
Report date November 17, 2025 · Filed November 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $12.48 · Expires 2035-11-17 | Direct | 1,517 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,517 · Balance 1,517 F1: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date"). F3: Issued in connection with the reporting person's employment with the Company. F2: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date").
F2: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date.
F3: Issued in connection with the reporting person's employment with the Company.
Quantum-Si Inc
Report date September 21, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,716,684 |
Ending reported balance
After 2026-09-22 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-21 · Sale · Disposed 5,172 · Balance 1,719,177 F1: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.75 to $0.762 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 2 · 2026-09-22 · Sale · Disposed 2,493 · Balance 1,716,684 F1: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.7511 to $0.7779 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.75 to $0.762 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.7511 to $0.7779 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
STAR EQUITY HOLDINGS, INC.
Report date February 28, 2018 · Filed March 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,696 |
Reported balance
After 2018-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-02-28 · Exercise / conversion · Acquired 6,617 · Balance 49,696 F1: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. |
| Common StockSEC Table I · non-derivative | Direct | 46,990 |
Reported balance
After 2018-02-28 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-02-28 · Tax withholding · Disposed 2,706 · Balance 46,990 F3: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 19,852 |
Reported balance
After 2018-02-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-02-28 · Exercise / conversion · Disposed 6,617 · Balance 19,852 F1: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. F4: On February 28, 2017, Mr. Keyes was granted 52,937 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 28, 2018, February 1, 2019, February 1, 2020 and February 1, 2021, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F6: Does not include Restricted Stock Units that did not vest and were cancelled. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 33,493 |
Reported balance
After 2018-02-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-02-28 · Grant · Acquired 33,493 · Balance 33,493 F1: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F5: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, subject to the reporting person continuing to provide service through each such date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 33,493 |
Reported balance
After 2018-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-02-28 · Grant · Acquired 33,493 · Balance 33,493 F1: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F7: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, with the vesting of 100% of each such tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
F2: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date.
F3: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold.
F4: On February 28, 2017, Mr. Keyes was granted 52,937 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 28, 2018, February 1, 2019, February 1, 2020 and February 1, 2021, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period.
F5: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, subject to the reporting person continuing to provide service through each such date.
F6: Does not include Restricted Stock Units that did not vest and were cancelled.
F7: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, with the vesting of 100% of each such tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2026 Filed Sep 23, 2026 23:45 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 2,493 | $0.76 | $1,896.67 |
DisclosureSEC source: 0001140361-26-037478 · form4.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,716,684 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.7511 to $0.7779 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 23:45 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 5,172 | $0.76 | $3,909.00 |
DisclosureSEC source: 0001140361-26-037478 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,719,177 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.75 to $0.762 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 00:23 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 4,117 | $0.90 | $3,701.18 |
DisclosureSEC source: 0001140361-26-026290 · form4.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,724,349 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.88 to $0.9291 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 00:23 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 4,116 | $0.96 | $3,940.66 |
DisclosureSEC source: 0001140361-26-026290 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728,466 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9212 to $1.005 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 21:09 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 37,381 | $1.00 | $37,194.10 |
DisclosureSEC source: 0001140361-26-016155 · form4.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,732,582 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9763 to $1.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:09 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 37,382 | $1.01 | $37,621.24 |
DisclosureSEC source: 0001140361-26-016155 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,769,963 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9811 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 23:02 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 4,422 | $0.83 | $3,655.23 |
DisclosureSEC source: 0001140361-26-010949 · form4.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,807,345 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.7973 to $0.8525 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 23:02 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 4,233 | $0.85 | $3,590.85 |
DisclosureSEC source: 0001140361-26-010949 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,811,767 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $0.8314 to $0.8718 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:19 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (Right to Buy) · Derivative | 780,847 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001140361-26-009612 · form4.xml · derivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780,847 Underlying: Class A Common Stock · 780,847 shares Expires 2036-03-12 F2 · derivative.exercise_date: The shares underlying this option shall vest in equal quarterly installments beginning on June 20, 2026 until fully vested, subject to continued service through the applicable vesting dates. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:19 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantClass A Common Stock | 652,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-009612 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,816,000 F1 · shares: The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in four equal annual installments beginning on April 20, 2027 until fully vested, subject to continued service through the applicable vesting date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 00:50 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 8,627 | $1.28 | $11,008.05 |
DisclosureSEC source: 0001557736-25-000006 · primary_doc.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,163,197 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.260 to $1.310 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 17, 2025 Filed Nov 20, 2025 02:07 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantOption to purchase common stock · Derivative | 1,517 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001683168-25-008576 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,517 Underlying: Common Stock · 1,517 shares Expires 2035-11-17 F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date"). F3 · price: Issued in connection with the reporting person's employment with the Company. F2 · derivative.exercise_date: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date. Read SEC document |
| September 23, 2025 Filed Sep 24, 2025 22:31 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 3,873 | $1.64 | $6,332.36 |
DisclosureSEC source: 0001140361-25-036046 · form4.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,171,824 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.57 to $1.79 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 22:31 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 3,873 | $1.68 | $6,516.71 |
DisclosureSEC source: 0001140361-25-036046 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,175,697 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.64 to $1.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 23, 2025 Filed Jun 24, 2025 23:03 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 8,624 | $1.61 | $13,918.27 |
DisclosureSEC source: 0001140361-25-023510 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179,570 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.55 to $1.68 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 22:34 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 8,626 | $1.39 | $11,951.32 |
DisclosureSEC source: 0001140361-25-010078 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188,194 F1 · kind: Represents shares sold pursuant to a mandatory Quantum-Si sell-to-cover provision for required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. Individual is not able to alter this mandatory sell-to-cover provision that is enacted at the grant date of the related restricted stock unit award. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.36 to $1.405 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 21:06 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantClass A Common Stock | 750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-008851 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,196,820 F1 · shares: The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in four (4) equal annual installments beginning on April 20, 2026, subject to continued service through the applicable vesting date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 10:01 UTC | Quantum-Si Inc QSI · Entity 6440 | PurchaseClass A Common Stock | 50,000 | $0.87 | $43,465.00 |
DisclosureSEC source: 0001140361-24-036920 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,820 Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 01:52 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantRestricted Stock Units · Derivative | 17,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-24-002289 · ownership.xml · derivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,428 Underlying: Common Stock · 17,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock. F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date. F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 01:52 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantOption to purchase common stock · Derivative | 17,500 | Not disclosed Strike: $0.26 | Not disclosed |
DisclosureSEC source: 0001683168-24-002289 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,928 Underlying: Common Stock · 17,500 shares Expires 2034-04-08 F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 12:25 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantClass A Common Stock | 346,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-013723 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,820 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal quarterly installments over four years beginning on June 20, 2024, subject to Mr. Keyes' continued service through the applicable vesting date. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 22:09 UTC | Quantum-Si Inc QSI · Entity 6440 | PurchaseClass A Common Stock | 50,000 | $1.61 | $80,500.00 |
DisclosureSEC source: 0001140361-24-011763 · form4.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| September 21, 2023 Filed Sep 25, 2023 22:27 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantOption to purchase common stock · Derivative | 68,961 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001683168-23-006686 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,914 Underlying: Common Stock · 68,961 shares Expires 2033-09-22 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| September 21, 2023 Filed Oct 12, 2023 22:01 UTC Amendment | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantOption to purchase common stock · Derivative | 39,475 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001683168-23-007109 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,428 Underlying: Common Stock · 39,475 shares Expires 2033-09-22 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:58 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001140361-23-025059 · form4.xml · derivative · entry 3 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Common Stock · 500,000 shares Expires 2033-05-15 F3 · derivative.exercise_date: The shares underlying this option vest in full if within three years of May 15, 2023 the closing price of the Issuer's Class A common stock is at least $20.00 (as adjusted) for 20 out of 30 consecutive trading days, subject to Mr. Keyes' continued service through the vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:58 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001140361-23-025059 · form4.xml · derivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Class A Common Stock · 500,000 shares Expires 2033-05-15 F2 · derivative.exercise_date: The shares underlying this option vest in full if within one year of May 15, 2023 the closing price of the Issuer's Class A common stock is at least $10.00 (as adjusted) for 20 out of 30 consecutive trading days, subject to Mr. Keyes' continued service through the vesting date. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:58 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001140361-23-025059 · form4.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Class A Common Stock · 1,000,000 shares Expires 2033-05-15 F1 · derivative.exercise_date: The shares underlying this option vest as to 25% on June 30, 2024, with the remainder vesting in 36 equal monthly installments at the end of each month thereafter, subject to Mr. Keyes' continued service through the applicable vesting date. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 19:34 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantCommon Stock | 11,100 | $0.30 | $3,294.48 |
DisclosureSEC source: 0001683168-22-001546 · ownership.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,100 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.2685 to $2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 21:00 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantOption to purchase common stock · Derivative | 32,000 | Not disclosed Strike: $1.80 | Not disclosed |
DisclosureSEC source: 0001683168-21-003001 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,559 Underlying: Common Stock · 32,000 shares Expires 2031-07-15 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC | CNS Pharmaceuticals, Inc. CNSP · Entity 8048 | GrantOption to purchase common stock · Derivative | 46,559 | Not disclosed Strike: $2.47 | Not disclosed |
DisclosureSEC source: 0001683168-20-001968 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,559 Underlying: Common Stock · 46,559 shares Expires 2030-06-12 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 19:46 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | GrantRestricted Stock Unit · Derivative | 33,493 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-18-000800 · form409271001key_03012018.xml · derivative · entry 5 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,493 Underlying: Common Stock · 33,493 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F7 · derivative.exercise_date: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, with the vesting of 100% of each such tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F7 · derivative.expiration_date: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, with the vesting of 100% of each such tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 19:46 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | GrantRestricted Stock Unit · Derivative | 33,493 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-18-000800 · form409271001key_03012018.xml · derivative · entry 4 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,493 Underlying: Common Stock · 33,493 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.exercise_date: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, subject to the reporting person continuing to provide service through each such date. F5 · derivative.expiration_date: These Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2019, February 28, 2020, February 28, 2021 and February 28, 2022, subject to the reporting person continuing to provide service through each such date. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 19:46 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionRestricted Stock Unit · Derivative | 6,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000800 · form409271001key_03012018.xml · derivative · entry 3 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,852 Underlying: Common Stock · 6,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_date: On February 28, 2017, Mr. Keyes was granted 52,937 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 28, 2018, February 1, 2019, February 1, 2020 and February 1, 2021, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F4 · derivative.expiration_date: On February 28, 2017, Mr. Keyes was granted 52,937 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 28, 2018, February 1, 2019, February 1, 2020 and February 1, 2021, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F6 · balance_after: Does not include Restricted Stock Units that did not vest and were cancelled. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 19:46 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Tax withholdingCommon Stock | 2,706 | $2.05 | $5,547.30 |
DisclosureSEC source: 0000921895-18-000800 · form409271001key_03012018.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,990 F3 · security: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 19:46 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionCommon Stock | 6,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000800 · form409271001key_03012018.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:18 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionRestricted Stock Unit · Derivative | 2,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000423 · form409271001key_02052018.xml · derivative · entry 6 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,519 Underlying: Common Stock · 2,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F6 · derivative.exercise_date: On February 1, 2016 the reporting person was granted 23,038 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 1, 2017, February 1, 2018, February 1, 2019 and February 1, 2020, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F6 · derivative.expiration_date: On February 1, 2016 the reporting person was granted 23,038 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 1, 2017, February 1, 2018, February 1, 2019 and February 1, 2020, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F5 · balance_after: Does not include Restricted Stock Units that did not vest and were cancelled. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:18 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionRestricted Stock Unit · Derivative | 3,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000423 · form409271001key_02052018.xml · derivative · entry 5 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,965 Underlying: Common Stock · 3,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_date: On February 1, 2015 the reporting person was granted 27,861 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 1, 2016, February 1, 2017, February 1, 2018 and February 1, 2019, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F4 · derivative.expiration_date: On February 1, 2015 the reporting person was granted 27,861 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units vest on each of February 1, 2016, February 1, 2017, February 1, 2018 and February 1, 2019, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F5 · balance_after: Does not include Restricted Stock Units that did not vest and were cancelled. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:18 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Tax withholdingCommon Stock | 1,178 | $2.30 | $2,709.40 |
DisclosureSEC source: 0000921895-18-000423 · form409271001key_02052018.xml · nonDerivative · entry 4 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,079 F3 · security: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:18 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionCommon Stock | 2,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000423 · form409271001key_02052018.xml · nonDerivative · entry 3 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:18 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Tax withholdingCommon Stock | 1,424 | $2.30 | $3,275.20 |
DisclosureSEC source: 0000921895-18-000423 · form409271001key_02052018.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,377 F3 · security: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 18:18 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionCommon Stock | 3,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-18-000423 · form409271001key_02052018.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 16:33 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | PurchaseCommon Stock | 1,450 | $3.47 | $5,031.50 |
DisclosureSEC source: 0000921895-17-002278 · form409271004_09072017.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,318 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.45 to $3.50, inclusive. Mr. Keyes undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:51 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | GrantRestricted Stock Unit · Derivative | 52,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-000556 · form409271004c_03012017.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,937 Underlying: Common Stock · 52,937 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2018, February 28, 2019, February 28, 2020 and February 28, 2021, with vesting of 50% of each such Restricted Stock Unit tranche to be further subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F2 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 28, 2018, February 28, 2019, February 28, 2020 and February 28, 2021, with vesting of 50% of each such Restricted Stock Unit tranche to be further subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 18:16 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionRestricted Stock Unit · Derivative | 5,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-000173 · form409271004a_02032017.xml · derivative · entry 6 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,279 Underlying: Common Stock · 5,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.exercise_date: On February 1, 2016 the reporting person was granted 23,038 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units fully vested on February 1, 2017 and the remaining Restricted Stock Units vest as to 25% of the units on each of February 1, 2018, February 1, 2019 and February 1, 2020, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F5 · derivative.expiration_date: On February 1, 2016 the reporting person was granted 23,038 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units fully vested on February 1, 2017 and the remaining Restricted Stock Units vest as to 25% of the units on each of February 1, 2018, February 1, 2019 and February 1, 2020, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 18:16 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionRestricted Stock Unit · Derivative | 6,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-000173 · form409271004a_02032017.xml · derivative · entry 5 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,931 Underlying: Common Stock · 6,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F4 · derivative.exercise_date: On February 1, 2015 the reporting person was granted 27,861 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units fully vested on February 1, 2016, 25% fully vested on February 1, 2017 and the remaining Restricted Stock Units vest as to 25% of the units on each of February 1, 2018 and February 1, 2019, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. F4 · derivative.expiration_date: On February 1, 2015 the reporting person was granted 27,861 Restricted Stock Units. As to this grant, 25% of the Restricted Stock Units fully vested on February 1, 2016, 25% fully vested on February 1, 2017 and the remaining Restricted Stock Units vest as to 25% of the units on each of February 1, 2018 and February 1, 2019, with vesting of 50% of each such Restricted Stock Unit tranche subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 18:16 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Tax withholdingCommon Stock | 2,521 | $4.95 | $12,478.95 |
DisclosureSEC source: 0000921895-17-000173 · form409271004a_02032017.xml · nonDerivative · entry 4 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,868 F3 · security: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 18:16 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionCommon Stock | 5,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-000173 · form409271004a_02032017.xml · nonDerivative · entry 3 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 18:16 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Tax withholdingCommon Stock | 3,050 | $4.95 | $15,097.50 |
DisclosureSEC source: 0000921895-17-000173 · form409271004a_02032017.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,630 F3 · security: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units. No shares were sold. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 18:16 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | Exercise / conversionCommon Stock | 6,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-17-000173 · form409271004a_02032017.xml · nonDerivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock. F2 · price: This transaction represents the settlement of Restricted Stock Units in shares of common stock on their scheduled vesting date. Read SEC document |
| November 04, 2016 Filed Nov 4, 2016 16:28 UTC | STAR EQUITY HOLDINGS, INC. DRAD · Entity 76212 | PurchaseCommon Stock | 500 | $4.20 | $2,100.00 |
DisclosureSEC source: 0000921895-16-006003 · form409271004_11042016.xml · nonDerivative · entry 2 Keyes Jeffry R. · CIK 0001557736 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,715 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.